Charles River Associates is a leading global consulting firm that offers economic, financial, and strategy expertise to major law firms, corporations, accounting firms, and governments around the world.
With proven skills in complex cases and exceptional strength in analytics, CRA consultants have provided astute guidance to clients in thousands of successful engagements. CRA is often engaged in antitrust class actions and other high-profile matters. We offer litigation and regulatory support, business strategy and planning, market and demand forecasting, policy analysis, and risk management consulting.
Our success stems from the outstanding capabilities of our consultants, many of whom are recognized as experts in their respective fields; our close relationships with a select group of respected academic and industry experts; and from a corporate philosophy that stresses interdisciplinary collaboration and responsive service.
Headquartered in Boston, the firm has offices internationally.
Established in 1970 and ranked among the top 100 law firms in America, Cozen O'Connor has 700 attorneys who help clients manage risk and make better business decisions. Our lawyers counsel clients on their most sophisticated legal matters in all areas of the law, including litigation, corporate, and regulatory law. We represent a broad array of leading global corporations and ambitious middle market companies, and serve their needs through 28 offices across two continents.
Timothy Snail, Ph.D., is a Vice President at Charles River Associates and a member of its Antitrust and Competition Economics practice. Dr. Snail is an economist specializing in antitrust, class actions and commercial damages matters. He has provided testimony in U.S. federal district court, state court, and in international arbitrations.
In class action matters, Dr. Snail has performed economic analyses of class certification relating to direct and indirect purchasers, merits, and damages for classes and opt outs.
In antitrust, Dr. Snail has evaluated antitrust merits and damages in matters involving monopolization, exclusive dealing, price fixing, bundling and tying, loyalty discounts, price discrimination, predatory pricing, refusals to deal, antitrust counterclaims arising from intellectual property disputes, patent misuse, and other issues. He has also performed economic analysis of market definition and competitive effects of mergers and acquisitions.
Dr. Snail has advised clients in a broad range of industries, including high-technology, telecommunications, transportation, building materials, paper, chemicals, plastics, oil refineries and storage, grocery products, vitamins and dietary supplements, beverages, cigarettes, retail tracking services, recorded music in digital media, auction houses, insurance, healthcare, life sciences and medical devices.
Dr. Snail has published and presented on economic analysis in damages, class action and false advertising matters. Dr. Snail has taught on topics in economics, econometrics, corporate finance and antitrust. He received a Ph.D. in economics from the University of California, Berkeley and a B.A. in mathematics from the University of Chicago.
David Reichenberg, a member of Cozen O'Connor’s antitrust group, focuses his work in all aspects of the practice, including litigation, counseling, and mergers and acquisitions. David regularly advises Fortune 500 clients on the antitrust implications of potential business initiatives and has counseled and litigated on the intersection of antitrust and intellectual property law. He has successfully represented many major technology companies on both the plaintiff and defense sides, such as successful litigation on behalf of Netflix in a class action in the Northern District of California, as well as on behalf of Universal Surveillance in a monopolization case. David has coordinated responses to investigations by the U.S. Department of Justice and Federal Trade Commission (on both the offensive and defensive sides). David currently serves as a vice chair on the Trial Practice Committee of the ABA Antitrust Section.